April 1, 2020 CytoDyn files investigational new drug application with FDA for coronavirus symptom treatment
April 1, 2020 Cytodyn Inc Files Modified IND And Protocol For Phase 2 Clinical Trial For Treatment Of Patients With Coronavirus With Leronlimab (Pro 140)
April 1, 2020 CytoDyn files modified IND and protocol for Phase 2 clinical trial of leronlimab as a treatment for coronavirus respiratory symptoms
April 1, 2020 CytoDyn sees positive test results from seven coronavirus patients in New York treated with its drug Leronlimab
April 1, 2020 CytoDyn"s therapy used to treat New York coronavirus patients shows "immunological benefits"
